Targeted muscle reinnervation for pain control in an elective transradial amputation

We thank our colleagues at The Royal Free Hospital for their letter. In response to their first criticism that our 'letter fails to clarify exactly what TMR is, and how it can benefit amputees', we would like to draw to the attention of Messrs Woollard and Kang that this correspondence was intended to highlight the benefits of targeted muscle reinnervation (TMR) in preventing neuroma pain. It was not intended to educate the readership on the scientific basis by which TMR can be used to control an external prosthesis.